Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 30 entries
Sorted by: Best Match Show Resources per page
Effect of Testosterone on Inflammatory Markers in the Development of Early Atherogenesis in the Testicular-Feminized Mouse Model.

Endocrine research

Kelly DM, Sellers DJ, Woodroofe MN, Jones TH, Channer KS.
PMID: 23167461
Endocr Res. 2013 Aug;38(3):125-138. doi: 10.3109/07435800.2012.735307. Epub 2012 Nov 20.

BACKGROUND: Low levels of serum testosterone in men are associated with cardiovascular disease. Clinical studies show that testosterone replacement therapy (TRT) can improve symptoms of cardiovascular disease and reduce the inflammatory burden evident in atherosclerosis.AIM: We used an in...

Cite
Kelly DM, Sellers DJ, Woodroofe MN, et al. Effect of Testosterone on Inflammatory Markers in the Development of Early Atherogenesis in the Testicular-Feminized Mouse Model. Endocr Res. 2012;38(3):125-138doi: 10.3109/07435800.2012.735307.
Kelly, D. M., Sellers, D. J., Woodroofe, M. N., Jones, T. H., & Channer, K. S. (2013). Effect of Testosterone on Inflammatory Markers in the Development of Early Atherogenesis in the Testicular-Feminized Mouse Model. Endocrine research, 38(3), 125-138. https://doi.org/10.3109/07435800.2012.735307
Kelly, Daniel M, et al. "Effect of Testosterone on Inflammatory Markers in the Development of Early Atherogenesis in the Testicular-Feminized Mouse Model." Endocrine research vol. 38,3 (2013): 125-138. doi: https://doi.org/10.3109/07435800.2012.735307
Kelly DM, Sellers DJ, Woodroofe MN, Jones TH, Channer KS. Effect of Testosterone on Inflammatory Markers in the Development of Early Atherogenesis in the Testicular-Feminized Mouse Model. Endocr Res. 2013 Aug;38(3):125-138. doi: 10.3109/07435800.2012.735307. Epub 2012 Nov 20. PMID: 23167461.
Copy Download .nbib Format: NLM
Comparison of the Effectiveness of Adult Height Prediction Methods in Children with Growth Hormone Deficiency.

Endocrine research

Erbaş İM, Ölmez Z, Paketçi A, Demir K, Böber E, Abacı A.
PMID: 33900130
Endocr Res. 2021 Aug;46(3):140-147. doi: 10.1080/07435800.2021.1916029. Epub 2021 Apr 26.

No abstract available.

Cite
Erbaş İM, Ölmez Z, Paketçi A, et al. Comparison of the Effectiveness of Adult Height Prediction Methods in Children with Growth Hormone Deficiency. Endocr Res. 2021;46(3):140-147doi: 10.1080/07435800.2021.1916029.
Erbaş, �. �. M., Ölmez, Z., Paketçi, A., Demir, K., Böber, E., & Abacı, A. (2021). Comparison of the Effectiveness of Adult Height Prediction Methods in Children with Growth Hormone Deficiency. Endocrine research, 46(3), 140-147. https://doi.org/10.1080/07435800.2021.1916029
Erbaş, İbrahim Mert, et al. "Comparison of the Effectiveness of Adult Height Prediction Methods in Children with Growth Hormone Deficiency." Endocrine research vol. 46,3 (2021): 140-147. doi: https://doi.org/10.1080/07435800.2021.1916029
Erbaş İM, Ölmez Z, Paketçi A, Demir K, Böber E, Abacı A. Comparison of the Effectiveness of Adult Height Prediction Methods in Children with Growth Hormone Deficiency. Endocr Res. 2021 Aug;46(3):140-147. doi: 10.1080/07435800.2021.1916029. Epub 2021 Apr 26. PMID: 33900130.
Copy Download .nbib Format: NLM
The association between insulin-like growth factor 1 levels within reference range and early postoperative remission rate in patients with Cushing's disease.

Endocrine research

Gezer E, Çetinarslan B, Selek A, Cantürk Z, Sözen M, Elen Ö, Baydemir C, Çabuk B, Ceylan S.
PMID: 33560156
Endocr Res. 2021 Aug;46(3):92-98. doi: 10.1080/07435800.2021.1883056. Epub 2021 Feb 09.

INTRODUCTION: The relationship between growth hormone (GH)/insulin-like growth factor 1 (IGF-1) and glucocorticoids (GC) was examined in various studies. Long-term GC treatment was shown to decrease GH concentration and, interestingly, to increase IGF-1 concentration. We performed a retrospective study...

Cite
Gezer E, Çetinarslan B, Selek A, et al. The association between insulin-like growth factor 1 levels within reference range and early postoperative remission rate in patients with Cushing's disease. Endocr Res. 2021;46(3):92-98doi: 10.1080/07435800.2021.1883056.
Gezer, E., Çetinarslan, B., Selek, A., Cantürk, Z., Sözen, M., Elen, �. �., Baydemir, C., Çabuk, B., & Ceylan, S. (2021). The association between insulin-like growth factor 1 levels within reference range and early postoperative remission rate in patients with Cushing's disease. Endocrine research, 46(3), 92-98. https://doi.org/10.1080/07435800.2021.1883056
Gezer, Emre, et al. "The association between insulin-like growth factor 1 levels within reference range and early postoperative remission rate in patients with Cushing's disease." Endocrine research vol. 46,3 (2021): 92-98. doi: https://doi.org/10.1080/07435800.2021.1883056
Gezer E, Çetinarslan B, Selek A, Cantürk Z, Sözen M, Elen Ö, Baydemir C, Çabuk B, Ceylan S. The association between insulin-like growth factor 1 levels within reference range and early postoperative remission rate in patients with Cushing's disease. Endocr Res. 2021 Aug;46(3):92-98. doi: 10.1080/07435800.2021.1883056. Epub 2021 Feb 09. PMID: 33560156.
Copy Download .nbib Format: NLM
Gonadotropins Are Related to Lean Mass in Healthy Postmenopausal Women.

Endocrine research

García-Martín A, Reyes-García R, García-Castro JM, Muñoz-Garach A, Escobar-Jiménez F, Muñoz-Torres M.
PMID: 23167440
Endocr Res. 2013 Aug;38(3):119-124. doi: 10.3109/07435800.2012.733987. Epub 2012 Nov 20.

BACKGROUND: It has been suggested that the changes in hormone levels that occur with menopause and aging are related to loss of muscle mass. However, the role of gonadotropins in this process is unknown.OBJECTIVES: To analyze the relationship between...

Cite
García-Martín A, Reyes-García R, García-Castro JM, et al. Gonadotropins Are Related to Lean Mass in Healthy Postmenopausal Women. Endocr Res. 2012;38(3):119-124doi: 10.3109/07435800.2012.733987.
García-Martín, A., Reyes-García, R., García-Castro, J. M., Muñoz-Garach, A., Escobar-Jiménez, F., & Muñoz-Torres, M. (2013). Gonadotropins Are Related to Lean Mass in Healthy Postmenopausal Women. Endocrine research, 38(3), 119-124. https://doi.org/10.3109/07435800.2012.733987
García-Martín, Antonia, et al. "Gonadotropins Are Related to Lean Mass in Healthy Postmenopausal Women." Endocrine research vol. 38,3 (2013): 119-124. doi: https://doi.org/10.3109/07435800.2012.733987
García-Martín A, Reyes-García R, García-Castro JM, Muñoz-Garach A, Escobar-Jiménez F, Muñoz-Torres M. Gonadotropins Are Related to Lean Mass in Healthy Postmenopausal Women. Endocr Res. 2013 Aug;38(3):119-124. doi: 10.3109/07435800.2012.733987. Epub 2012 Nov 20. PMID: 23167440.
Copy Download .nbib Format: NLM
Effect of Pioglitazone on Serum Uric Acid Levels in Newly Diagnosed, Drug-Naïve Patients with Type 2 Diabetes.

Endocrine research

Kutoh E, Hori T.
PMID: 23216460
Endocr Res. 2013 Aug;38(3):151-159. doi: 10.3109/07435800.2012.745128. Epub 2012 Dec 05.

OBJECTIVES: The aim of this study was to investigate the effect of pioglitazone on serum uric acid (UA) levels and several diabetic parameters in drug-naïve subjects with type 2 diabetes mellitus (T2DM).PATIENTS AND METHODS: The patients (n = 68)...

Cite
Kutoh E, Hori T. Effect of Pioglitazone on Serum Uric Acid Levels in Newly Diagnosed, Drug-Naïve Patients with Type 2 Diabetes. Endocr Res. 2012;38(3):151-159doi: 10.3109/07435800.2012.745128.
Kutoh, E., & Hori, T. (2013). Effect of Pioglitazone on Serum Uric Acid Levels in Newly Diagnosed, Drug-Naïve Patients with Type 2 Diabetes. Endocrine research, 38(3), 151-159. https://doi.org/10.3109/07435800.2012.745128
Kutoh, Eiji, and Hori, Tadataka. "Effect of Pioglitazone on Serum Uric Acid Levels in Newly Diagnosed, Drug-Naïve Patients with Type 2 Diabetes." Endocrine research vol. 38,3 (2013): 151-159. doi: https://doi.org/10.3109/07435800.2012.745128
Kutoh E, Hori T. Effect of Pioglitazone on Serum Uric Acid Levels in Newly Diagnosed, Drug-Naïve Patients with Type 2 Diabetes. Endocr Res. 2013 Aug;38(3):151-159. doi: 10.3109/07435800.2012.745128. Epub 2012 Dec 05. PMID: 23216460.
Copy Download .nbib Format: NLM
Glucose Tolerance in Mice is Linked to the Dose of the p53 Transactivation Domain.

Endocrine research

Franck D, Tracy L, Armata HL, Delaney CL, Jung DY, Ko HJ, Ong H, Kim JK, Scrable H, Sluss HK.
PMID: 23102272
Endocr Res. 2013 Aug;38(3):139-150. doi: 10.3109/07435800.2012.735735. Epub 2012 Oct 26.

AIM: To test the transactivation domain-mediated control of glucose homeostasis by the tumor suppressor p53.BACKGROUND: The tumor suppressor p53 has a critical role in maintenance of glucose homeostasis. Phosphorylation of Ser18 in the transaction domain of p53 controls the...

Cite
Franck D, Tracy L, Armata HL, et al. Glucose Tolerance in Mice is Linked to the Dose of the p53 Transactivation Domain. Endocr Res. 2012;38(3):139-150doi: 10.3109/07435800.2012.735735.
Franck, D., Tracy, L., Armata, H. L., Delaney, C. L., Jung, D. Y., Ko, H. J., Ong, H., Kim, J. K., Scrable, H., & Sluss, H. K. (2013). Glucose Tolerance in Mice is Linked to the Dose of the p53 Transactivation Domain. Endocrine research, 38(3), 139-150. https://doi.org/10.3109/07435800.2012.735735
Franck, Debra, et al. "Glucose Tolerance in Mice is Linked to the Dose of the p53 Transactivation Domain." Endocrine research vol. 38,3 (2013): 139-150. doi: https://doi.org/10.3109/07435800.2012.735735
Franck D, Tracy L, Armata HL, Delaney CL, Jung DY, Ko HJ, Ong H, Kim JK, Scrable H, Sluss HK. Glucose Tolerance in Mice is Linked to the Dose of the p53 Transactivation Domain. Endocr Res. 2013 Aug;38(3):139-150. doi: 10.3109/07435800.2012.735735. Epub 2012 Oct 26. PMID: 23102272; PMCID: PMC5074905.
Copy Download .nbib Format: NLM
The Relationship Between Insulin Use And Increased Mortality In Patients With COVID-19 And Diabetes: A Meta-Analysis.

Endocrine research

Wang W, Sun Y, Wang S, Sun Y.
PMID: 34409914
Endocr Res. 2021 Aug 19;1-7. doi: 10.1080/07435800.2021.1967376. Epub 2021 Aug 19.

PURPOSE: The purpose of this study is to review observational studies on the effect of insulin use and mortality in patients with COVID-19 and diabetes.METHODS: A systematic literature search was performed using the PubMed, Medline, EMBASE, and Cochrane Library...

Cite
Wang W, Sun Y, Wang S, et al. The Relationship Between Insulin Use And Increased Mortality In Patients With COVID-19 And Diabetes: A Meta-Analysis. Endocr Res. 2021;1-7doi: 10.1080/07435800.2021.1967376.
Wang, W., Sun, Y., Wang, S., & Sun, Y. (2021). The Relationship Between Insulin Use And Increased Mortality In Patients With COVID-19 And Diabetes: A Meta-Analysis. Endocrine research, 1-7. https://doi.org/10.1080/07435800.2021.1967376
Wang, Wanteng, et al. "The Relationship Between Insulin Use And Increased Mortality In Patients With COVID-19 And Diabetes: A Meta-Analysis." Endocrine research vol. (2021): 1-7. doi: https://doi.org/10.1080/07435800.2021.1967376
Wang W, Sun Y, Wang S, Sun Y. The Relationship Between Insulin Use And Increased Mortality In Patients With COVID-19 And Diabetes: A Meta-Analysis. Endocr Res. 2021 Aug 19;1-7. doi: 10.1080/07435800.2021.1967376. Epub 2021 Aug 19. PMID: 34409914.
Copy Download .nbib Format: NLM
Relationship between Functional .

Endocrine research

Jahantigh D, Mirani Sargazi F, Sargazi S, Saravani R, Ghazaey Zidanloo S, Heidari Nia M, Piri M.
PMID: 33870836
Endocr Res. 2021 Aug;46(3):129-139. doi: 10.1080/07435800.2021.1914079. Epub 2021 Apr 17.

No abstract available.

Cite
Jahantigh D, Mirani Sargazi F, Sargazi S, et al. Relationship between Functional . Endocr Res. 2021;46(3):129-139doi: 10.1080/07435800.2021.1914079.
Jahantigh, D., Mirani Sargazi, F., Sargazi, S., Saravani, R., Ghazaey Zidanloo, S., Heidari Nia, M., & Piri, M. (2021). Relationship between Functional . Endocrine research, 46(3), 129-139. https://doi.org/10.1080/07435800.2021.1914079
Jahantigh, Danial, et al. "Relationship between Functional ." Endocrine research vol. 46,3 (2021): 129-139. doi: https://doi.org/10.1080/07435800.2021.1914079
Jahantigh D, Mirani Sargazi F, Sargazi S, Saravani R, Ghazaey Zidanloo S, Heidari Nia M, Piri M. Relationship between Functional . Endocr Res. 2021 Aug;46(3):129-139. doi: 10.1080/07435800.2021.1914079. Epub 2021 Apr 17. PMID: 33870836.
Copy Download .nbib Format: NLM
Oocyte Survival and Development during Follicle Formation and Folliculogenesis in Mice Lacking Aromatase.

Endocrine research

Toothaker JM, Roosa K, Voss A, Getman SM, Pepling ME.
PMID: 34866531
Endocr Res. 2021 Dec 04;1-11. doi: 10.1080/07435800.2021.2011907. Epub 2021 Dec 04.

No abstract available.

Cite
Toothaker JM, Roosa K, Voss A, et al. Oocyte Survival and Development during Follicle Formation and Folliculogenesis in Mice Lacking Aromatase. Endocr Res. 2021;1-11doi: 10.1080/07435800.2021.2011907.
Toothaker, J. M., Roosa, K., Voss, A., Getman, S. M., & Pepling, M. E. (2021). Oocyte Survival and Development during Follicle Formation and Folliculogenesis in Mice Lacking Aromatase. Endocrine research, 1-11. https://doi.org/10.1080/07435800.2021.2011907
Toothaker, Jessica M, et al. "Oocyte Survival and Development during Follicle Formation and Folliculogenesis in Mice Lacking Aromatase." Endocrine research vol. (2021): 1-11. doi: https://doi.org/10.1080/07435800.2021.2011907
Toothaker JM, Roosa K, Voss A, Getman SM, Pepling ME. Oocyte Survival and Development during Follicle Formation and Folliculogenesis in Mice Lacking Aromatase. Endocr Res. 2021 Dec 04;1-11. doi: 10.1080/07435800.2021.2011907. Epub 2021 Dec 04. PMID: 34866531.
Copy Download .nbib Format: NLM
Possible Contributions of Nongenomic Actions of Thyroid Hormones to the Vasculopathic Complex of COVID-19 Infection.

Endocrine research

Davis PJ, Lin HY, Hercbergs A, Keating KA, Mousa SA.
PMID: 34775877
Endocr Res. 2021 Nov 14;1-6. doi: 10.1080/07435800.2021.1972307. Epub 2021 Nov 14.

BACKGROUND: Integrin αvβ3 is a cell membrane structural protein whose extracellular domain contains a receptor for L-thyroxine (T4). The integrin is expressed in rapidly dividing cells and its internalization is prompted by T4. The protein binds viruses and we...

Cite
Davis PJ, Lin HY, Hercbergs A, et al. Possible Contributions of Nongenomic Actions of Thyroid Hormones to the Vasculopathic Complex of COVID-19 Infection. Endocr Res. 2021;1-6doi: 10.1080/07435800.2021.1972307.
Davis, P. J., Lin, H. Y., Hercbergs, A., Keating, K. A., & Mousa, S. A. (2021). Possible Contributions of Nongenomic Actions of Thyroid Hormones to the Vasculopathic Complex of COVID-19 Infection. Endocrine research, 1-6. https://doi.org/10.1080/07435800.2021.1972307
Davis, Paul J, et al. "Possible Contributions of Nongenomic Actions of Thyroid Hormones to the Vasculopathic Complex of COVID-19 Infection." Endocrine research vol. (2021): 1-6. doi: https://doi.org/10.1080/07435800.2021.1972307
Davis PJ, Lin HY, Hercbergs A, Keating KA, Mousa SA. Possible Contributions of Nongenomic Actions of Thyroid Hormones to the Vasculopathic Complex of COVID-19 Infection. Endocr Res. 2021 Nov 14;1-6. doi: 10.1080/07435800.2021.1972307. Epub 2021 Nov 14. PMID: 34775877.
Copy Download .nbib Format: NLM
The Ratios of Triglycerides and C-reactive protein to High density-lipoprotein -cholesterol as valid biochemical markers of the Nascent Metabolic Syndrome.

Endocrine research

Jialal I, Adams-Huet B.
PMID: 34080928
Endocr Res. 2021 Nov;46(4):196-202. doi: 10.1080/07435800.2021.1930039. Epub 2021 Jun 03.

No abstract available.

Cite
Jialal I, Adams-Huet B. The Ratios of Triglycerides and C-reactive protein to High density-lipoprotein -cholesterol as valid biochemical markers of the Nascent Metabolic Syndrome. Endocr Res. 2021;46(4):196-202doi: 10.1080/07435800.2021.1930039.
Jialal, I., & Adams-Huet, B. (2021). The Ratios of Triglycerides and C-reactive protein to High density-lipoprotein -cholesterol as valid biochemical markers of the Nascent Metabolic Syndrome. Endocrine research, 46(4), 196-202. https://doi.org/10.1080/07435800.2021.1930039
Jialal, Ishwarlal, and Adams-Huet, Beverley. "The Ratios of Triglycerides and C-reactive protein to High density-lipoprotein -cholesterol as valid biochemical markers of the Nascent Metabolic Syndrome." Endocrine research vol. 46,4 (2021): 196-202. doi: https://doi.org/10.1080/07435800.2021.1930039
Jialal I, Adams-Huet B. The Ratios of Triglycerides and C-reactive protein to High density-lipoprotein -cholesterol as valid biochemical markers of the Nascent Metabolic Syndrome. Endocr Res. 2021 Nov;46(4):196-202. doi: 10.1080/07435800.2021.1930039. Epub 2021 Jun 03. PMID: 34080928.
Copy Download .nbib Format: NLM
Sarcopenia is Associated with Reduced Survival following Surgery for Adrenocortical Carcinoma.

Endocrine research

de Jong MC, Patel N, Hassan-Smith Z, Mihai R, Khan S.
PMID: 34340645
Endocr Res. 2021 Aug 03;1-10. doi: 10.1080/07435800.2021.1954942. Epub 2021 Aug 03.

AIM: Adrenocortical cancer (ACC) is an aggressive malignancy and robust prognostic factors remain unclear. The presence of sarcopenia has been shown to negatively impact survival for other malignancies, but has not been extensively analyzed in ACC.METHODS: Patients who underwent...

Cite
de Jong MC, Patel N, Hassan-Smith Z, et al. Sarcopenia is Associated with Reduced Survival following Surgery for Adrenocortical Carcinoma. Endocr Res. 2021;1-10doi: 10.1080/07435800.2021.1954942.
de Jong, M. C., Patel, N., Hassan-Smith, Z., Mihai, R., & Khan, S. (2021). Sarcopenia is Associated with Reduced Survival following Surgery for Adrenocortical Carcinoma. Endocrine research, 1-10. https://doi.org/10.1080/07435800.2021.1954942
de Jong, Mechteld C, et al. "Sarcopenia is Associated with Reduced Survival following Surgery for Adrenocortical Carcinoma." Endocrine research vol. (2021): 1-10. doi: https://doi.org/10.1080/07435800.2021.1954942
de Jong MC, Patel N, Hassan-Smith Z, Mihai R, Khan S. Sarcopenia is Associated with Reduced Survival following Surgery for Adrenocortical Carcinoma. Endocr Res. 2021 Aug 03;1-10. doi: 10.1080/07435800.2021.1954942. Epub 2021 Aug 03. PMID: 34340645.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 30 entries